anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

230,221-230,280 of 319,975

filter-aware
74
The slide uses a heatmap to visualize synergy (green = yes, light green = no) across 6 drug combinations and 14 patient samples.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
75
Includes statistical significance markers (asterisks) and safety observation regarding body weight.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
76
Uses Bliss Independence Model for synergy calculation. Includes a heatmap of synergy across subtypes and dose-response curves for two specific models (DMS79 and H345).Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
77
The heatmap displays AUC values for 16 patient samples across three treatments.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
78
The slide uses a two-column layout to contrast PK and Toxicology findings.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
79
MIDD = Model-informed Drug DevelopmentExscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
80
The background features a stylized molecular structure, emphasizing the biotech/pharma context.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
81
The slide uses a three-column layout to summarize the value proposition of a drug candidate.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
82
The slide uses a biological pathway diagram to illustrate the mechanism of action.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
83
Exscientia | Investor Presentation Deck | 93 slidesExscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
84
The slide uses a biological mechanism argument to establish a safety/efficacy advantage for the drug candidate '565.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
85
The slide uses a heatmap-style table to visualize performance against criteria, with a specific focus on UGT1A1 inhibition risk.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
86
The slide uses a linear process flow to explain a complex drug discovery workflow.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
87
The slide highlights the application of computational chemistry (molecular dynamics) to drug discovery, specifically focusing on binding site analysis.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
88
The slide presents preclinical efficacy data for a MALT1 inhibitor ('565) in combination with Ibrutinib.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
89
The slide uses dose-response curves to show IC50 and selectivity.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
90
The table uses a heatmap-style color coding (red/green) to indicate risk levels.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
91
Exscientia | Investor Presentation Deck | 93 slidesExscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
92
Exscientia | Investor Presentation Deck | 93 slidesExscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
93
This is a standard corporate contact/disclaimer slide.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
01
Slide 1
Exscientia | Results Presentation Deck | 22 slidesExscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
02
Exscientia | Results Presentation Deck | 22 slidesExscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
03
Exscientia | Results Presentation Deck | 22 slidesExscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
04
The slide uses a Gantt-style visualization to represent drug development stages.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations 1 hit
05
The slide uses a circular, iterative process flow to represent the R&D lifecycle.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations 1 hit
06
The chart uses a visual metaphor of shifting a curve to represent economic improvement in drug development.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · NeedLoop · Before After1 hit
07
Exscientia | Results Presentation Deck | 22 slidesExscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · NeedLoop · Before After1 hit
08
The slide uses a timeline-like axis to represent ranking improvement from a broad prompt to a precision prompt.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Loop · Before After1 hit
09
The slide uses a numbered process flow (1-4) mapped to a visual representation of an LLM interface.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Loop · Before After1 hit
10
Exscientia | Results Presentation Deck | 22 slidesExscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations 1 hit
11
The slide uses a circular process flow to represent a closed-loop R&D system.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations 1 hit
12
The slide uses a circular process diagram to represent a continuous improvement loop.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations 1 hit
13
Exscientia | Results Presentation Deck | 22 slidesExscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
14
The slide uses a human anatomy diagram to map specific cancer types to their physiological locations.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
15
The slide outlines a standard clinical trial progression from dose escalation to expansion, with specific patient enrollment targets.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
16
The table uses a color-coded heatmap (green/yellow/red/grey) to indicate performance against criteria.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
17
The slide uses a circular diagram centered on a human silhouette to integrate three key pillars of the drug development strategy.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
18
Exscientia | Results Presentation Deck | 22 slidesExscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
19
Exscientia | Results Presentation Deck | 22 slidesExscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
20
Includes footnotes regarding tax withholding, cash runway, and shares outstanding.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
21
Exscientia | Results Presentation Deck | 22 slidesExscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
22
Exscientia | Results Presentation Deck | 22 slidesExscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
Includes company logo, date, and a series of icons representing business areas.FiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations 1 hit
02
FiscalNote | Results Presentation Deck | 31 slidesFiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations 1 hit
03
The slide uses a grid of icons and big numbers to present a company snapshot.FiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations 1 hit
04
The slide uses a split-screen layout with a photo collage on the left and a dark purple text block on the right.FiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations Loop · Golden Circle1 hit
05
The slide uses a three-row layout to categorize customers into Government Agencies, Corporates (sub-segmented into Large Enterprise and Mid-Market/SMB), and Non-Profits & NGOs.FiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations Loop · Golden Circle1 hit
06
The slide uses a logo-grid layout to demonstrate market reach and credibility.FiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations Loop · Golden Circle1 hit
07
Uses a collage of images showing CEOs in regulatory hearings to visually reinforce the 'Regulatory Pressure' theme.FiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations Loop · Golden Circle1 hit
08
The slide uses a visual metaphor of a building (Capitol) as a source point for market expansion.FiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations Beat · Problem1 hit
09
FiscalNote | Results Presentation Deck | 31 slidesFiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations Beat · Solution1 hit
10
The slide uses a funnel-like process diagram to show how diverse data sources are ingested and processed.FiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations Beat · Solution1 hit
11
The slide uses visual evidence (screenshots and event photos) to establish credibility.FiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations 1 hit
12
The left chart is a conceptual growth matrix showing ACV expansion based on user count and product usage. The right side shows two specific customer growth stories.FiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations 1 hit
13
The slide uses a timeline-based expansion journey on the right and a bar chart for ARR growth on the bottom left.FiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations 1 hit
14
The chart x-axis labels are slightly redundant (2022 appears twice).FiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations 1 hit
15
FiscalNote | Results Presentation Deck | 31 slidesFiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
16
The slide uses a grouping strategy to compare FiscalNote against peers in different sectors, highlighting valuation multiples and recent M&A activity.FiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
17
FiscalNote | Results Presentation Deck | 31 slidesFiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
18
The slide uses a staircase metaphor to represent sequential or cumulative strategic achievements.FiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations Loop · Cost Of Inaction1 hit